rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-8-10
|
pubmed:abstractText |
Positron emission tomography (PET) is a non-invasive imaging modality used in the diagnosis and staging of breast cancer. However, several factors can affect fluoro-deoxyglucose (FDG) uptake by a tumor. To clarify the parameters that most affect FDG accumulation in tumors, the relationship between standardized uptake values (SUVs) and clinicopathological factors and immunohistopathological analysis was investigated in breast cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1340-6868
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
260-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17690502-Adenocarcinoma, Scirrhous,
pubmed-meshheading:17690502-Adult,
pubmed-meshheading:17690502-Aged,
pubmed-meshheading:17690502-Breast Neoplasms,
pubmed-meshheading:17690502-Carcinoma, Ductal, Breast,
pubmed-meshheading:17690502-Female,
pubmed-meshheading:17690502-Fluorodeoxyglucose F18,
pubmed-meshheading:17690502-Humans,
pubmed-meshheading:17690502-Injections, Intravenous,
pubmed-meshheading:17690502-Lymphatic Metastasis,
pubmed-meshheading:17690502-Middle Aged,
pubmed-meshheading:17690502-Neoplasm Staging,
pubmed-meshheading:17690502-Neoplasms, Hormone-Dependent,
pubmed-meshheading:17690502-Positron-Emission Tomography,
pubmed-meshheading:17690502-Radiopharmaceuticals,
pubmed-meshheading:17690502-Receptor, erbB-2,
pubmed-meshheading:17690502-Receptors, Estrogen,
pubmed-meshheading:17690502-Receptors, Progesterone
|
pubmed:year |
2007
|
pubmed:articleTitle |
The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
|
pubmed:affiliation |
Department of Surgical Oncology, Dokkyo Medical University, Shimotsuge, Tochigi, Japan.
|
pubmed:publicationType |
Journal Article
|